Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions.

Jinani Jayasekera Joseph A Sparano Suzanne C O'Neill Young Chandler Claudine Isaacs Allison W Kurian Lawrence H KushiClyde B SchechterJeanne S Mandelblatt

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)

Our validated clinical decision tool is flexible, readily adaptable to include new therapies, and can support discussions about genomic testing and early breast cancer treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
copy number
prognostic factors
decision making
peritoneal dialysis
gene expression
free survival